Prestige Biologics Decides on New Facility Investment... KRW 80.6 Billion Scale
[Asia Economy Reporter Lee Junhyung] Prestige Biologics announced on the 19th that it will invest approximately 80.6 billion KRW in the expansion and extension of its second factory.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- KOSPI 10,000 Era Survival Strategy: Buy the Leading Stocks
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
This investment amount is 78.18% of its equity capital.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.